ChemicalBook--->CAS DataBase List--->2718971-08-3

2718971-08-3

2718971-08-3 Structure

2718971-08-3 Structure
IdentificationBack Directory
[Name]

Sulfamide, N-[2-[1-(7,8-dimethoxyimidazo[1,2-a]quinazolin-5-yl)-4-piperidinyl]ethyl]-
[CAS]

2718971-08-3
[Synonyms]

Enpp-1-IN-8
Sulfamide, N-[2-[1-(7,8-dimethoxyimidazo[1,2-a]quinazolin-5-yl)-4-piperidinyl]ethyl]-
[Molecular Formula]

C19H26N6O4S
[MOL File]

2718971-08-3.mol
[Molecular Weight]

434.51
Chemical PropertiesBack Directory
[density ]

1.50±0.1 g/cm3(Predicted)
[pka]

11.00±0.60(Predicted)
Hazard InformationBack Directory
[Uses]

Enpp-1-IN-8 is a potent inhibitor of ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp-1). The ENPP 1 has broad specificity and can cleave a variety of substrates, including phosphodiester bonds of nucleotides and nucleotide sugars and pyrophosphate bonds nucleotides and nucleotide sugars. Enpp-1-IN-8 has the potential for the research of cancer and infectious diseases (extracted from patent WO2021203772A1, compound 51)[1].
[References]

[1] Bang Fu, et al. Ectonucleotide pyrophosphatase-phosphodiesterase 1 inhibitors,compositions and uses thereof. Patent WO2021203772A1.
2718971-08-3 suppliers list
Company Name: TargetMol Chemicals Inc.
Tel: +17819995354 , +17819995354
Website:
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Website: https://www.targetmol.cn/
Tags:2718971-08-3 Related Product Information

  • HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms | About Us
  • All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
    According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.
  • Copyright © 2023 ChemicalBook All rights reserved.